Literature DB >> 5114632

2,2'-O-cyclocytidine, an antitumor cytidine analog resistant to cytidine deaminase.

A Hoshi, F Kanazawa, K Kuretani, M Saneyoshi, Y Arai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5114632

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


× No keyword cloud information.
  6 in total

1.  Comparative study of the antiviral activity of acyl derivatives of 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine and other nucleosides against encephalitis in mice.

Authors:  S Nishiyama; K Sato; T Yamanaka; J G Moffatt
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

2.  Survival of L1210 leukemia cells and normal hematopoietic stem cells following in vivo administration of cyclocytidine.

Authors:  F Valeriote; I D Muntz; T J Vietti
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

3.  Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine.

Authors:  R Ohno; K Kimura; K Ota; Y Miura; A Hoshino; K Hattori; M Hirano; M Ito; T Maekawa; T Nakamura
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

4.  The pharmacokinetics of subcutaneous bolus cytosine arabinoside in an arachis oil plus aluminium distearate suspension.

Authors:  M L Slevin; E M Piall; A Johnston; D A Levison; G W Aherne; S B Tree; T A Lister
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

5.  Clinical pharmacology of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in patients with hematologic malignancies.

Authors:  T Ueda; T Nakamura; D Kagawa; M Uchida; N Domae; M Sugiyama; Y Ueda; M Sasada; H Uchino
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Antitumor activity and pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate: an orally active derivative of 1-beta-D-arabinofuranosylcytosine.

Authors:  K Kodama; M Morozumi; K Saitoh; A Kuninaka; H Yoshino; M Saneyoshi
Journal:  Jpn J Cancer Res       Date:  1989-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.